Financial News · Live Terminal

Page 101 of 718

Zebra Technologies Invests in Apera AI to Strengthen Automation Capabilities

Zebra Technologies (ZBRA) said Wednesday its venture arm has invested in Apera AI to support the development of artificial intelligence-driven automation solutions.Financial details of the investment weren't provided.The investment focuses on Apera AI's 4D Vision technology, which enables robots to perform complex tasks in dynamic manufacturing environments using real-time visual intelligence, Zebra said.Shares of Zebra Technologies were down 1.5% in early Wednesday trading.Price: $215.91, Change: $-3.33, Percent Change: -1.52%

$ZBRA

Australia1d ago

Graphic Packaging Signs Deal With NextEra Energy Resources for 250-MW Solar Plant in Texas

Graphic Packaging (GPK) said Wednesday it has signed a virtual power purchase agreement with NextEra Energy's (NEE) Energy Resources unit to build a 250-megawatt solar plant in West Texas.The planned Selenite Springs Energy Center in the Electric Reliability Council of Texas market is expected to begin commercial operations at the end of 2027, with Graphic Packaging set to be the sole buyer of its renewable energy attribute certificates, covering about 43% of its 2025 electricity usage across the US and Canada.The Texas project is expected to add new US-made renewable energy to the ERCOT grid, helping address growing electricity demand while supporting grid reliability and cost efficiency, the company said.Price: $9.72, Change: $-0.01, Percent Change: -0.05%

$GPK$NEE

Australia1d ago

Morgan Stanley Adjusts Price Target on Universal Health Services to $212 From $233, Maintains Equalweight Rating

Universal Health Services (UHS) has an average rating of overweight and mean price target of $228.93, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $165.80, Change: $+3.26, Percent Change: +2.01%

$UHS

Showing 2001-2020 of 14348

Financial News · Live Terminal

Zebra Technologies Invests in Apera AI to Strengthen Automation Capabilities

Graphic Packaging Signs Deal With NextEra Energy Resources for 250-MW Solar Plant in Texas

Morgan Stanley Adjusts Price Target on Universal Health Services to $212 From $233, Maintains Equalweight Rating

Zebra Technologies Invests in Apera AI to Strengthen Automation Capabilities

Graphic Packaging Signs Deal With NextEra Energy Resources for 250-MW Solar Plant in Texas

Morgan Stanley Adjusts Price Target on Universal Health Services to $212 From $233, Maintains Equalweight Rating

Research Alert: Teva Q1: Innovative Growth Drives Performance Amid Generics Headwinds

Piper Sandler Adjusts F5 Price Target to $356 From $325, Maintains Overweight Rating

Wedbush Lifts Price Target on Varonis Systems to $37 From $35, Keeps Outperform Rating

Stephens Adjusts Price Target on Universal Health Services to $205 From $235, Maintains Equalweight Rating

JPMorgan Adjusts American Tower Price Target to $240 From $245, Maintains Overweight Rating

Raymond James Adjusts American Tower Price Target to $240 From $229, Maintains Strong Buy Rating

Argus Adjusts Price Target on Ventas to $92 From $88, Maintains Buy Rating

Evercore ISI Adjusts Price Target on Ventas to $95 From $94, Maintains Outperform Rating

EMEA Oil Update: Crude Climbs as UAE Exits OPEC Amid Iran War

Wedbush Boosts Price Target on AXT Inc. to $80 From $28, Keeps Outperform Rating

Brief: Bank of Canada's April MPR Says Outlook Depends on Outcome of CUSMA Trade Negotiations With U.S., Duration and Severity of Iran War

JPMorgan Adjusts Avery Dennison Price Target to $185 From $205, Maintains Overweight Rating

Truist Securities Adjusts Avery Dennison Price Target to $213 From $222, Maintains Outperform Rating

Morgan Stanley Adjusts Price Target on NXP Semiconductors to $335 From $299, Maintains Overweight Rating

Needham Adjusts Price Target on NXP Semiconductors to $300 From $250, Maintains Buy Rating

Hutchmed Says China Grants Priority Review for Sovleplenib in Autoimmune Hemolytic Anemia

Piper Sandler Adjusts Cincinnati Financial Price Target to $161 From $156, Maintains Neutral Rating